Internal Medicine, Endocrinology, Diabetes, & Metabolism · Caguas, PR
NPI
1952763476
Since 2016
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
Urb Profesional Center Building, 2 Carr Munoz Rivera Esquina Goyco Ofi 310
Caguas, PR, 00725
Phone (787) 399-9121
Groups this clinician bills Medicare through
Medicare paid, 2024
$5,907
78 services
Medicare patients, 2024
19
Average age 73
Drug cost, 2024
$1.7M
5,158 prescriptions
Company payments, 2025
$1,097
From 12 companies
Medicare prescription drug claims, 2024
In 2024, the drug Ivan A Serrano Santiago prescribed most often to Medicare patients was Ozempic (Semaglutide), with 516 prescriptions and refills. In total Ivan A Serrano Santiago wrote 5,158 Medicare prescriptions that cost $1.7M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-06-17.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Ozempic Semaglutide | 516 | 533 | 77 | $518K |
| Synthroid Levothyroxine Sodium | 512 | 648 | 104 | $31K |
| Atorvastatin Calcium Generic | 343 | 456 | 89 | $2,717 |
| Metformin Hcl Generic | 305 | 396 | 74 | $1,701 |
| Rosuvastatin Calcium Generic | 304 | 407 | 63 | $3,082 |
| Trulicity Dulaglutide | 258 | 282 | 40 | $280K |
| Lantus Insulin Glargine,hum.Rec.Anlog | 176 | 253 | 45 | $21K |
| Synjardy Xr Empagliflozin/Metformin Hcl | 168 | 178 | 31 | $108K |
| Glipizide Generic | 162 | 200 | 37 | $1,840 |
| Mounjaro Tirzepatide | 146 | 146 | 22 | $156K |
| Trijardy Xr Empaglifloz/Linaglip/Metformin | 140 | 160 | 32 | $89K |
| Jardiance Empagliflozin | 136 | 162 | 30 | $99K |
| Jentadueto Xr Linagliptin/Metformin Hcl | 116 | 116 | 24 | $62K |
| Metformin Hcl Er Metformin Hcl | 116 | 126 | 29 | $995 |
| Levothyroxine Sodium Generic | 115 | 137 | 30 | $965 |
Brand drugs: 2,811 claims; generic drugs: 2,243 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ivan A Serrano Santiago $1,097 ($1,097 in general payments such as food, travel and fees) from 12 companies. The largest payer was Eli Lilly Export S.A. Puerto Rico Branch with $172.
| Company | Payments | Amount |
|---|---|---|
| Eli Lilly Export S.A. Puerto Rico Branch LLY | 7 | $172 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $138 |
| Novo Nordisk Inc NVO | 9 | $137 |
| Abbott Laboratories ABT | 5 | $118 |
| Beta Bionics, Inc. BBNX | 1 | $116 |
| Amgen Inc. AMGN | 6 | $112 |
| Medtronic, Inc. MDT | 2 | $80.21 |
| Lilly USA, LLC LLY | 4 | $76.82 |
| Dexcom, Inc. DXCM | 3 | $60 |
| Radius Health, Inc. | 2 | $50 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.